• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Anti-Human Platelet Antigen (HPA)-1a Prophylactic Method to Prevent FNAIT

An editorial published in the journal Transfusion, discusses the potential for developing anti-human platelet antigen (HPA)-1a prophylactic methods to prevent…

July 20, 2012

Study Identifies Most Effective Ways to Increase Blood Donations

According to the American Red Cross, only 3% of the US population donates blood.  A systematic review of 29 studies,…

July 20, 2012

Obstetricians and Public Cord Blood Banking

A survey by the National Marrow Donor Program found that obstetricians are familiar with the use of donated cord blood…

July 20, 2012

Synthetic Platelets Offer Potential Benefits for Platelet-Associated Disorders

Professor Nishit Doshi and colleagues from the University of California, Santa  Barbara, the Scripps Research Institute, and Sanford-Burnham Medical Research…

July 20, 2012

Aspirin Increases Bleeding Risk

In a study published in the Journal of the American Medical Association (JAMA), researchers found that regular use of low-dose…

July 20, 2012

FDA Report Shows Decreasing Trend of Transfusion-Related Fatalities

An annual report of transfusion fatalities for fiscal year(FY) 2011, released by the FDA’s Center for Biologics Evaluation and Research,…

July 20, 2012

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 64
  • Page 65
  • Page 66

Primary Sidebar

Latest News

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley